Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.10%
SPX
-0.03%
IXIC
+0.13%
FTSE
-0.58%
N225
+0.32%
AXJO
-0.36%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

NVO has been in the news 313% more than usual

Apr 29, 2025, 6:31 PM
5.19%
What does NVO do
It seems that there is no content provided for summarization. Please provide the text you would like me to summarize.
NVO has been in the news recently: Novo Nordisk is partnering with telehealth providers to offer its weight-loss drug Wegovy at a starting price of $499 per month, aiming to expand patient access. Additionally, a lawsuit has been filed against Novo Nordisk by Cilette Mitchell, who claims that the company's drugs Ozempic and Wegovy caused her permanent vision loss.
📡️ Health Care
In The News

More Signals

Feature in Progress
This section is under development. Check back soon for updates!